Published in Clin Exp Immunol on December 01, 2014
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet (2012) 4.85
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant (2009) 1.67
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant (2011) 1.66
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant (2011) 1.16
Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol (2011) 1.07
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot study. Am J Transplant (2007) 1.06
Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology. Am J Transplant (2013) 0.98
Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies. Am J Transplant (2014) 0.92